Netherlands · Monitoring · 2024 RACE-9: active surveillance as a treatment strategy
Maastricht University Medical Center FibriCheck's telemonitoring guides real-time rate control in a watchful-waiting approach to acute AF, without additional hardware.
Objective
To evaluate whether a watchful-waiting approach to acute atrial fibrillation is at least as beneficial as routine care consisting of early or delayed cardioversion.
Approach
In this multi-centre randomised controlled trial initiated by Maastricht University Medical Center, rate-control medication is administered to relieve symptoms while FibriCheck’s telemonitoring infrastructure guides rate control in real time, without additional hardware. After discharge from the emergency department, patients keep using FibriCheck for four weeks to monitor for recurrences and guide ongoing therapy.
Outcome
Because FibriCheck’s platform is scalable and compatible with a wide range of consumer devices, a watchful-waiting approach has real potential to adapt therapy to regular, real-time data and improve outcomes for atrial fibrillation outpatients.